News
FSNUY
12.12
+1.51%
0.18
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Kepler Capital
TipRanks · 2d ago
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Jefferies
TipRanks · 3d ago
UBS Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 3d ago
J.P. Morgan Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 3d ago
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from Barclays
TipRanks · 3d ago
Fresenius SE Non-GAAP EPS of €0.82, revenue of €5.74B; reaffirms FY26 outlook
Seeking Alpha · 3d ago
Weekly Report: what happened at FSNUY last week (0427-0501)?
Weekly Report · 5d ago
Deutsche Bank Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 11:42
J.P. Morgan Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 11:03
Barclays Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/30 07:09
Weekly Report: what happened at FSNUY last week (0420-0424)?
Weekly Report · 04/27 10:34
Fresenius SE price target lowered to EUR 53 from EUR 57 at Citi
TipRanks · 04/24 16:36
Fresenius SE & Co. KGaA (0OO9) Receives a Buy from UBS
TipRanks · 04/23 08:45
Fresenius SE & Co. KGaA (0OO9) Receives a Hold from Goldman Sachs
TipRanks · 04/23 07:05
Fresenius SE & Co. KGaA (0OO9) Gets a Buy from J.P. Morgan
TipRanks · 04/22 06:16
Barclays Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 04/21 06:07
Fresenius SE price target lowered to EUR 56 from EUR 58 at Morgan Stanley
TipRanks · 04/20 15:45
Weekly Report: what happened at FSNUY last week (0413-0417)?
Weekly Report · 04/20 10:29
Fresenius SE & Co. KGaA (0OO9) Gets a Buy from Deutsche Bank
TipRanks · 04/20 09:58
Weekly Report: what happened at FSNUY last week (0406-0410)?
Weekly Report · 04/13 10:34
More
Webull provides a variety of real-time FSNUY stock news. You can receive the latest news about Fresenius through multiple platforms. This information may help you make smarter investment decisions.
About FSNUY
Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.